CLYDE BIOSCIENCES LIMITED

Active Motherwell

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CLYDE BIOSCIENCES LIMITED

Research and experimental development on biotechnology

Founded 7 Mar 2012 Active Motherwell, Scotland 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

DUNWILCO (1739) LIMITED 7 Mar 2012 — 19 Jul 2012
Accounts Submitted 28 Apr 2026 Next due 30 Apr 2026 2 months overdue
Confirmation Submitted 26 Feb 2026 Next due 12 Mar 2027 9 months remaining
Net assets £-2M £95K 2025 year on year
Total assets £719K £440K 2025 year on year
Total Liabilities £2M £345K 2025 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

Biocity Scotland Bo'Ness Road Motherwell Lanarkshire ML1 5UH Scotland

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CLYDE BIOSCIENCES LIMITED (SC418838), an active life sciences and medical technology company based in Motherwell, Scotland. Incorporated 7 Mar 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Aug → 31 Jul 2025
Type total-exemption-full
Next accounts 31 Jul 2025
Due by 30 Apr 2026 2 months overdue

Net Assets, Total Assets & Total Liabilities (2014–2025)

Cash in Bank

£220.86k

Increased by £56.10k (+34%)

Net Assets

-£1.59M

Increased by £95.13k (+6%)

Total Liabilities

£2.30M

Increased by £345.02k (+18%)

Turnover

N/A

Employees

9

Debt Ratio

320%

Decreased by 382 (-54%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Jul Year End
2024
31 Jul Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Aug 2012Seed
Investor 3Apr 2015Series A
Investor 4Apr 2015Series A

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (11)

Epidarex Capital Ii Lp
40.6%
269,248
Scottish Enterprise
22.7%
150,590

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Epidarex Capital Partners Limited

Unknown

Active
Notified 16 Mar 2021
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent

Epidarex Capital Management Llp

Ceased 21 Mar 2021

Ceased

Group Structure

Group Structure

CLYDE BIOSCIENCES LIMITED Current Company

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Apr 2026AccountsAnnual accounts made up to 31 Jul 2025
12 Mar 2026Persons With Significant ControlCessation of Epidarex Capital Management Llp as a person with significant control on 21 Mar 2021
10 Mar 2026Persons With Significant ControlCessation of A Person with Significant Control as a person with significant control on 10 Mar 2026
10 Mar 2026Persons With Significant ControlEpidarex Capital Partners Limited notified as a person with significant control
26 Feb 2026Confirmation StatementConfirmation statement made on 26 Feb 2026 with updates
28 Apr 2026 Accounts

Annual accounts made up to 31 Jul 2025

12 Mar 2026 Persons With Significant Control

Cessation of Epidarex Capital Management Llp as a person with significant control on 21 Mar 2021

10 Mar 2026 Persons With Significant Control

Cessation of A Person with Significant Control as a person with significant control on 10 Mar 2026

10 Mar 2026 Persons With Significant Control

Epidarex Capital Partners Limited notified as a person with significant control

26 Feb 2026 Confirmation Statement

Confirmation statement made on 26 Feb 2026 with updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

1 months ago on 28 Apr 2026

Cessation of Epidarex Capital Management Llp as a person with significant control on 21 Mar 2021

3 months ago on 12 Mar 2026

Cessation of A Person with Significant Control as a person with significant control on 10 Mar 2026

3 months ago on 10 Mar 2026

Epidarex Capital Partners Limited notified as a person with significant control

3 months ago on 10 Mar 2026

Confirmation statement made on 26 Feb 2026 with updates

3 months ago on 26 Feb 2026